Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  Biochemical Engineering >  Amino Acids and Derivatives >  Valine derivatives >  MOC-D-Valine

MOC-D-Valine

Basic information Safety Supplier Related

MOC-D-Valine Basic information

Product Name:
MOC-D-Valine
Synonyms:
  • MOC-D-Valine
  • MOC-D-VAL-OH
  • (2R)-2-(methoxycarbonylamino)-3-methylbutanoic acid
  • (R)-2-(Methoxycarbonylamino)-3-methylbutanoic acid
  • (R)-2-((Methoxycarbonyl)aMino)-4-Methylbutanoic acid
  • Methoxycarbonyl-D-Valine
  • N-METHOXYCARBONYL-D-VALINE
  • (R)-(+)-N-(Methoxycarbonyl)valine
CAS:
171567-86-5
MF:
C7H13NO4
MW:
175.18
Mol File:
171567-86-5.mol
More
Less

MOC-D-Valine Chemical Properties

Boiling point:
315.9±25.0 °C(Predicted)
Density 
1.154±0.06 g/cm3(Predicted)
storage temp. 
Sealed in dry,Room Temperature
pka
4.44±0.10(Predicted)
Appearance
White to off-white Solid
More
Less

Safety Information

HS Code 
2924297099
More
Less

MOC-D-Valine Usage And Synthesis

Uses

(R)-2-((Methoxycarbonyl)amino)-3-methylbutanoic Acid is used in the synthetic preparation of dipeptide-capped bis-phenylimidazole derivatives as hepatitis C virus NS5A replication complex inhibitors.

Synthesis

640-68-6

79-22-1

171567-86-5

The general procedure for the synthesis of (R)-2-(methoxycarbonylamino)-3-methylbutanoic acid from D-valine and methyl chloroformate was as follows: sodium carbonate (276 mg, 2.6 mmol) was added to an aqueous sodium hydroxide solution (5 mL, 1 M, 5 mmol) containing D-valine (586 mg, 5.00 mmol), and the resultant solution was subsequently cooled in an ice water bath. . Methyl chloroformate (0.420 mL, 5.40 mmol) was slowly added dropwise with stirring. After completion of the dropwise addition, the ice water bath was removed and the reaction mixture was continued to be stirred at room temperature for 3.25 hours. After completion of the reaction, the reaction mixture was washed with ether (3 x 9 mL). The aqueous phase was again cooled in an ice water bath and acidified to pH 1-2 with concentrated hydrochloric acid and then extracted with dichloromethane (3 x 9 mL). The organic phases were combined, dried with anhydrous magnesium sulfate, filtered, and concentrated under reduced pressure to afford the target product (R)-2-(methoxycarbonylamino)-3-methylbutyric acid (760 mg, 87% yield) as a white solid. The product was characterized by 1H NMR (DMSO-d6, δ= 2.5 ppm, 300 MHz): 12.54 (s, 1H), 7.32 (d, 1H), 3.84 (t, 1H), 3.54 (s, 3H), 2.03 (m, 1H), 0.87 (d, 6H).

References

[1] ACS Medicinal Chemistry Letters, 2014, vol. 5, # 3, p. 255 - 258
[2] European Journal of Medicinal Chemistry, 2017, vol. 125, p. 87 - 100
[3] Patent: KR2017/31307, 2017, A. Location in patent: Paragraph 0161-0163
[4] RSC Advances, 2018, vol. 8, # 55, p. 31803 - 31821

MOC-D-ValineSupplier

BeiJing Hwrk Chemicals Limted
Tel
0757-86329057 18934348241
Email
sales4.gd@hwrkchemical.com
Energy Chemical
Tel
021-021-58432009 400-005-6266
Email
sales8178@energy-chemical.com
Adamas Reagent, Ltd.
Tel
400-6009262 16621234537
Email
chenyj@titansci.com
Shanghai Hanhong Scientific Co.,Ltd.
Tel
021-54306202 13764082696
Email
info@hanhongsci.com
ChemStrong Scientific Co.,Ltd
Tel
0755-0755-66853366 13670046396
Email
sales@chem-strong.com